LivingGLP1
Study S000807

Impact of Semaglutide Administration on Tobacco Use Behavior and Related Mechanisms Among Smokers With Obesity

Registration

Registration
NCT06986993
Acronym
ONSET
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE4
Masking
DOUBLE
Status
RECRUITING
Enrollment
40
Start
2024-07-01
Primary completion
2028-05-30
Lead sponsor
University of Oklahoma
Conditions
Tobacco Use
Interventions
DRUG:Semaglutide; DRUG:Placebo
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Cigarette smoking [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.